Fidelity Fund Touts China Health Stocks Citing Japan-Like Trends.

A top-performing equity fund, Fidelity Emerging Asia, is investing in healthcare stocks in China due to similarities in demographic and export trends with Japan. As China's population ages and becomes wealthier, hospitals, pharmaceutical firms, and medical equipment makers are expected to benefit. The healthcare industry in China is attracting investors due to cheap valuations and a softer regulatory stance. Chinese healthcare companies are also out-licensing drugs to foreign manufacturers, and exports are expected to increase. Fidelity's fund has seen strong returns, and artificial intelligence is predicted to further enhance the efficiency of China's healthcare industry. [Extracted from the article]